3055B |
Mexiletine, Blood |
3055SP |
Mexiletine, Serum/Plasma |
3092SP |
Moricizine, Serum/Plasma |
3157U |
Cotinine and Anabasine from Secondary Exposure, Urine |
3225SP |
Nuedexta®, Serum/Plasma |
3227B |
Beta-Blockers Panel, Blood |
3227SP |
Beta-Blockers Panel, Serum/Plasma |
3227U |
Beta-Blockers Panel, Urine |
3250SP |
Oxalate, Serum/Plasma |
3426B |
Perfluorooctanoic Acid, Blood Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3427SP |
Perfluoroalkyl Substances (PFAS), Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3428SP |
PFASure TM, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3429SP |
PFASure TM Expanded, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3704SP |
Phenylephrine, Serum/Plasma |
3720B |
Phenylpropanolamine, Blood |
3720SP |
Phenylpropanolamine, Serum/Plasma |
3720U |
Phenylpropanolamine, Urine |
3976B |
Propafenone, Blood |
3976SP |
Propafenone, Serum/Plasma |